Neurxstem

NeurXstem was born out of a bold vision: to reshape the future of brain and spinal cord care through the power of predictive and precision functional genomics. Rooted in decades of research and driven by an urgent clinical need, we set out to create a new class of therapies — designed not just to treat symptoms, but to regenerate function at its source. Focus Areas • Neurodegeneration: Dementia & Alzheimer’s Research • Genomic Innovation: DNA & Cellular Division Technologies • AI-Driven Healthcare: Predictive Diagnostics, Drug Discovery & Personalized Medicine • Intellectual Property: Patent Licensing – Medical & Pharmaceutical Applications • Strategic Partnerships: Joint Ventures with Medical Institutions & Foundations • Market Expansion: Longevity & Beauty Industry Integration Dr Rene Anand - Lord Mark T Reardon - Dr Peter Cruse -